| Date | Form | Description | Docs | XBRL | Pages |
| 06/11/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 03/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 09/08/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/26/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 08/18/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 05/22/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
44 |
Latest News & Events
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Read More...Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer
Read More...